Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline
- 1 December 2016
- journal article
- review article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 169, 180-189
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Predictors of 10‐year smoking abstinence in smokers abstinent for 1 year after treatmentAddiction, 2016
- Pharmacological Treatments for Smoking CessationJAMA, 2014
- Probability and predictors of relapse to smoking: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Drug and Alcohol Dependence, 2013
- Nicotine receptor partial agonists for smoking cessation2012
- Use of Varenicline for 4 Weeks Before Quitting SmokingArchives of internal medicine (1960), 2011
- Generalizability of clinical trials for alcohol dependence to community samplesDrug and Alcohol Dependence, 2008
- Chi‐squared and Fisher–Irwin tests of two‐by‐two tables with small sample recommendationsStatistics in Medicine, 2007
- Under-use of smoking-cessation treatmentsAmerican Journal of Preventive Medicine, 2005
- Nicotine Dependence and Psychiatric Disorders in the United StatesArchives of General Psychiatry, 2004
- ‘Research’ versus ‘real-world’ patients: representativeness of participants in clinical trials of treatments for cocaine dependenceDrug and Alcohol Dependence, 1999